Skip to main content
. 2015 Dec 28;48(3):917–927. doi: 10.4143/crt.2015.265

Fig. 2.

Fig. 2.

Overall survival (OS) (A), disease-free survival (DFS) (B), locoregional failure-free survival (LRFFS) (C), and distant failure-free survival (DFFS) (D) curves for the concurrent chemoradiotherapy arm (CRT) and neoadjuvant chemotherapy arm (NCT) arms in subgroup with stage IV disease patients younger than 60 years.